[Community Member]

Check out my latest column, where I had the privilege to interview Dr. S. Sahay, a PH specialist from Houston Methodist Hospital!

Dr. Sahay is the co-director of the hospital’s PH Comprehensive Care Program, and he shares valuable insights about potential new treatments for PH.

Dig in this exclusive piece as we dive into the world of cutting-edge options for PH patients. Share your takeaways, and let’s talk about this exciting news!

https://pulmonaryhypertensionnews.com/columns/behind-every-new-treatment-ph-are-dedicated-professionals/

[Community Member]

Thanks for the information, Jen!

[Community Member]

It’s my pleasure, @Vicky Olsen. It’s hopeful for us all in the PH community!💜

How are you doing, my PHriend? We would love a brief update. Are you looking forward to the holidays?

[Community Member]

Thanks so much for keeping us up to date!!

[Community Member]

Hi, @Sarah Beth Shingler. I apologize for missing your thanks. I saw it today and wanted to let you know that I have shared two new FDA-approved treatments for PH this week.

But yes, we must try to stay updated on all of our treatment options. 💜
How are you feeling this week?

[Community Member]

Jen

Just discovered a new medication for PAH. This came out of the Wall Street Journal:

The drug, which will sell under the name Winrevair, treats a condition called pulmonary arterial hypertension that affects nearly 40,000 people in the U.S. In 2021.

According to the article it specifically treats the causes of PHA, especially like CTEPH. Here is the link. Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives out of the WSJ for the 26th.

I would imagine that Biotech would be aware of it.

Randy

wsj.com

wsj.com

wsj.com

[Community Member]

Hey @Randolph Reynolds, this is the awaited treatment for sostaracept. I shared the news article from our PH News website a few minutes earlier. The link to that post is below.

https://pulmonaryhypertensionnews.com/forums/forums/topic/and-we-are-on-a-roll-fda-approves-sotatercept-now-winrevair/

You are quick, my PHriend. I am slow after my appointment this morning. But we shared this news and had another treatment approved late Friday. I shared that one, too.

I hope you are doing OK this week and pacing as you pack and prepare for this big move. When is this going to occur again? You know my mind is getting old and forgetful. Hehe.

pulmonaryhypertensionnews.com

And, we are on a roll, FDA approves sotatercept, now Winrevair! - Research and Development - Pulmonary Hypertension News Forums

And, we are on a roll, FDA approves sotatercept, now Winrevair! - Research and Development - Pulmonary Hypertension News Forums

[Community Member]

Here are the latest updates on the Corsair Phase 1 trial of the treprostinil skin patch for PAH. Our PH News teams share there were positive results in the pre-clinical trials. You can read the full article below.

What are your takeaways? Would wearing a transdermal patch be something of interest to you? Why/Why not?

https://pulmonaryhypertensionnews.com/news/corsair-planning-phase-1-trial-treprostinil-skin-patch-pah/

pulmonaryhypertensionnews.com

Corsair planning Phase 1 trial to test treprostinil skin patch for PAH

Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).